Therapy of Lung Cancer-Any progress? An Overview of the Last Decade

[1]  J. Pedersen‐Bjergaard,et al.  Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small cell carcinoma of the lung , 1985 .

[2]  H. Hansen,et al.  Treatment policy of surgery in small cell carcinoma of the lung: retrospective analysis of a series of 874 consecutive patients. , 1985, Thorax.

[3]  D. Gandara,et al.  Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  J. Sculier,et al.  Progress in chemotherapy of non-small cell lung cancer. , 1984, European journal of cancer & clinical oncology.

[5]  G. Atassi.  Do we need new chemosensitive experimental models? , 1984, European journal of cancer & clinical oncology.

[6]  G. Green,et al.  Mitomycin‐C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second‐line regimen in lung cancer , 1984, American journal of clinical oncology.

[7]  R. Livingston,et al.  Long-term survival and toxicity in small cell lung cancer. Southwest Oncology Group study. , 1984, The American journal of medicine.

[8]  H. Hansen,et al.  Phase II study of vindesine, cisplatin, and hexamethylmelamine (VCH) in small cell carcinoma of the lung. , 1984, Cancer treatment reports.

[9]  R. Souhami,et al.  Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial. , 1984, British medical journal.

[10]  H. Hansen,et al.  Cyclic alternating 'non-cross resistant' chemotherapy in the management of small cell anaplastic carcinoma of the lung. , 1984, Cancer Treatment Reviews.

[11]  M. Tucker,et al.  Increased incidence of acute nonlymphocytic leukemia following therapy in patients with small cell carcinoma of the lung. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  S. Seeber,et al.  Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin. , 1984, Cancer treatment reports.

[13]  D. Osoba,et al.  VP‐16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer , 1984, Cancer.

[14]  J. Herman,et al.  Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  J. Minna,et al.  Small cell lung cancer 1973-1983: early progress and recent obstacles. , 1984, International journal of radiation oncology, biology, physics.

[16]  F. Hirsch,et al.  Continuous versus alternating combination chemotherapy for advanced small cell carcinoma of the lung. , 1983, Cancer research.

[17]  H. Hansen,et al.  Etoposide (VP-16) in the treatment of lung cancer. , 1983, Cancer treatment reviews.

[18]  R. Dillman,et al.  Failure of low-dose, total-body irradiation to augment combination chemotherapy in extensive-stage small cell carcinoma of the lung. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J. Cox,et al.  Is chest radiotherapy necessary in any or all patients with small cell carcinoma of the lung? Yes. , 1983, Cancer treatment reports.

[20]  A. Goldhirsch,et al.  Mitomycin, hexamethylmelamine, and vindesine as second-line treatment for small cell cancer of the lung. , 1982, Cancer treatment reports.

[21]  D. V. Van Echo,et al.  CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma. , 1982, Cancer treatment reports.

[22]  L. Norton,et al.  Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. , 1982, Annals of internal medicine.

[23]  O. Kokron,et al.  Ifosfamid versus Ifosfamid + CCNU in der Behandlung des inoperablen kleinzelligen Bronchuskarzinoms , 1982 .

[24]  W. Henderson,et al.  Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75. , 1981, JAMA.

[25]  F. Hirsch,et al.  Clonal heterogeneity of small-cell anaplastic carcinoma of the lung demonstrated by flow-cytometric DNA analysis. , 1980, Cancer research.

[26]  A. Feinstein,et al.  An analysis of the reporting of results in lung cancer drug trials. , 1980, Journal of the National Cancer Institute.

[27]  J. Greenberger,et al.  Multimodality therapy for malignant mesothelioma based on a study of natural history. , 1980, The American journal of medicine.

[28]  J. Cox,et al.  Total body irradiation vs. chemotherapy as a systemic adjuvant for small cell carcinoma of the lung. , 1979, International journal of radiation oncology, biology, physics.

[29]  A. Elbadawi,et al.  Long-term survivorship in small-cell anaplastic lung carcinoma. , 1979, Cancer treatment reports.

[30]  Lokich Jj,et al.  Undifferentiated small-cell (oat-cell) carcinoma of lung: prospects for long-term survival. , 1977, New York state journal of medicine.

[31]  R. Rapp,et al.  The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo. , 1968, Radiology.

[32]  F. Cavalli,et al.  Phase-II study of vindesine and hexamethylmelamine in patients with relapsing small cell carcinoma of the lung , 2004, Cancer Chemotherapy and Pharmacology.

[33]  M. Spang‐Thomsen,et al.  Limitations and Potentials of In Vitro Sensitivity Testing of Human Small Cell Carcinoma of the Lung , 1986 .

[34]  H. Hansen,et al.  Commentary: current status of chemotherapy for non-small cell lung cancer. , 1981, Cancer treatment reports.

[35]  T. Pajak,et al.  A randomized combined modality trial in small cell carcinoma of the lung comparison of combination chemotherapy‐radiation therapy versus cyclophosphamide‐radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation , 1980, Cancer.

[36]  J. Lundar.  Small-celled anaplastic lung carcinoma. Patients alive five years after operation. , 1970, Scandinavian journal of respiratory diseases. Supplementum.